Cognitive and Behavioral Problems as a Complication of COVID-19 Infection: Is It Organic or More Functional?
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 6900
Special Issue Editor
Interests: cognitive disorders; neuropsychology; degenerative diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With the increasing number of people infected with SARS-CoV-2, it is likely that beyond the initial wave of acute symptoms, many chronic sequelae of the infection will become apparent in the coming months and years. The long-term sequelae of infection are still poorly understood, but a growing number of reports suggest that they include cognitive and behavioral complications. Many recovering patients report persistent fatigue, pain, palpitations, headaches and dizziness, insomnia, depression, anxiety, memory problems, and difficulty concentrating (“brain fog”).
A variety of things can contribute to mental health decline. Demographic, medical, and general health factors that affect cognitive frailty, but also pulmonary factors leading to hypoxia, vascular factors causing ischemia, neurogenic factors causing neuronal damage, or immune system activation/disregulation are all considered in the pathomechanism of cognitive and functional decline.
On the other hand, critical care patients may experience psychological distress and trauma due to concerns about disease outcome, traumatic memories, or stigma. In at least some cases, mental health problems may be transient and result from functional rather than organic changes.
Data on COVID-19 and its long-term mental health complications are lacking, and many details regarding the mechanisms underlying psychiatric and cognitive impairment remain poorly understood.
Therefore, this Special Issue of the Journal of Clinical Medicine aims to focus on current research on possible factors contributing to short- and long-term mental health deterioration after SARS-CoV-2 infection. We welcome research articles, debates, and reviews.
Dr. Aleksandra Klimkowicz-Mrowiec
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-COV-2
- COVID-19
- cognitive impairment
- dementia
- mental health
- pathomechanism
- diagnosis
- prevention
- treatment
- prognosis
